Navigation Links
Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
Date:2/12/2008

The Private Securities Litigation Reform Act of 1995 permits this discussion.

This press release and/or the financial results attached to this press release include "Adjusted Net Income," "Basic Adjusted Income per Common Share," "Adjusted Net Income Guidance, "Basic Adjusted Income per Common Share Guidance," and "Diluted Adjusted Income Per Common Share," amounts that are considered "non-GAAP financial measures" under SEC rules. As required, we have provided reconciliations of these measures. Additional required information is located in the Form 8-K furnished to the SEC in connection with this press release.

CEPHALON, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

REVENUES:

Sales $439,497 $473,347 $1,727,299 $1,720,172

Other revenues 10,474 11,335 45,339 43,897

449,971 484,682 1,772,638 1,764,069

COSTS AND EXPENSES:

Cost of sales 89,897 88,171 341,867 338,784

Research and development 95,037 129,340 369,115 424,239

Selling, general and

administrative 207,837 219,334 735,799 689,492

Settlement reserve - - 425,000 -

Impairment charge - - - 12,417

Acquired in-process research

and development - 5,000 - 5,000

392,771 441,845 1,871,781 1,469,932 '/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), ... through the production of ethanol from non-food cellulosic wastes, has ... list of the "50 Hottest Companies in Bioenergy;" the company,s ... voters rank BlueFire Ethanol among the top 20 bioenergy companies ...
(Date:12/3/2009)... PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: ... announced a voluntary recall of five lots and voluntary ... (ADHD) patch Daytrana ® . Shire is taking this ... in the future may not meet their release liner ...
(Date:12/2/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) announced today ... quarter and fiscal year 2009 on December 16, 2009, at ... at 4:45 p.m. ET Martek will conduct a conference call ... may listen to the call live via webcast by visiting ...
(Date:12/2/2009)... 2 Nearly 600 medical research executives, scientists, policy ... approaches and innovative funding strategies at the inaugural ... the Washington-based center of the Milken Institute, convened ... needed to turn a scientific discovery into an accessible ...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
... primary burdens facing a patent applicant before the ... requirement that the claimed invention is not obvious under ... defense raised in patent infringement cases. Yet, overcoming obviousness ... lawsuits, was relatively routine. This changed last week when ...
... Wis . - Logistics Health, Inc ., a ... has established a Web-based optimization tool to help client ... announcement, which came at the American Occupational Health ... would launch Health & Productivity Management Optimization, according to ...
... Jim Doyle has announced that Berbee Information Networks ... Campus, will receive $250,000 in state Technology Zone tax credits. ... new 43,250-square-foot office building and a 51,500-square-foot data center in ... Technology Campus. , ,The project is expected to cost ...
Other Biology Technology:High court sends message on patent obviousness 2High court sends message on patent obviousness 3High court sends message on patent obviousness 4
(Date:12/4/2009)... thinking about amyloids the fibrous protein deposits associated with ... up a potential new area for therapeutics. , It was ... proteins sometimes known as fibres - are inert, but that ... damage cells and cause disease. , But in a ...
(Date:12/3/2009)... coating on windows or solar panels that repels grime ... electric car? New Tel Aviv University research, just published ... assembling peptides at the nano-scale level that could make ... years. , Operating in the range of 100 nanometers ...
(Date:12/3/2009)... undergo a personality change in warmer water, according to an ... species more aggressive. , Experiments with two species of young ... first time that some reef fish are either consistently timid, ... more marked as water temperatures rise. , A slight lift ...
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2A window that washes itself? 2Fish with attitude: Some like it hot 2Erie County home to plant never before recorded in Pa 10118 1Erie County home to plant never before recorded in Pa 10118 2Swine Flu Virus Not Mutating Making Vaccine a Good Match 58364 1Swine Flu Virus Not Mutating Making Vaccine a Good Match 58364 2Swine Flu Virus Not Mutating Making Vaccine a Good Match 58364 3BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease 58361 1BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease 58361 2
... The life expectancy for patients with human immunodeficiency ... since the late 1990s thanks to advancements in antiretroviral ... at Birmingham (UAB) and Simon Fraser University in Vancouver, ... nearly 40 percent drop in AIDS deaths among 43,355 ...
... that have turned ,green, can potentially contain a naturally occurring ... health according to a review paper published in the latest ... Food and Agriculture (JSFA). , However, the good news ... to eliminate most of the GAs to reduce the risk. ...
... Glasses embedded with a telescope promise to make it ... do other activities requiring sharper distance vision. Schepens Eye ... glasses over earlier devices in an article published in ... , mailed in print form to subscribers this ...
Other Biology News:Anti-HIV therapy boosts life expectancy more than 13 years 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3
Our Histology, Immunohistochemistry and tissue arrays services include samples processing, different type of staning, histollogical stains, image analysis, tissue arrays, immunohistochemistry, etc....
Mouse monoclonal antibody raised against a partial recombinant FBXO24. NCBI Entrez Gene ID = FBXO24...
...
... pLivSelect is a direct antibiotic-based selection ... solely on colony survival, eliminating the need ... inexpensive process provides close to 100% accuracy ... ideal platform for robot colony picking. ...
Biology Products: